메뉴 건너뛰기




Volumn 54, Issue 6, 2010, Pages 2338-2344

Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; KBPA101; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

EID: 77952616726     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01142-09     Document Type: Article
Times cited : (51)

References (48)
  • 1
    • 0026696807 scopus 로고
    • Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients
    • Bruderer, U., S. J. Cryz, Jr., U. B. Schaad, M. Deusinger, J. U. Que, and A. B. Lang. 1992. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. J. Infect. Dis. 166:344-349.
    • (1992) J. Infect. Dis. , vol.166 , pp. 344-349
    • Bruderer, U.1    Cryz Jr., S.J.2    Schaad, U.B.3    Deusinger, M.4    Que, J.U.5    Lang, A.B.6
  • 3
    • 0029863296 scopus 로고    scopus 로고
    • Ventilator-associated pneumonia due to Pseudomonas aeruginosa
    • Crouch Brewer, S., R. G. Wunderink, C. B. Jones, and K. V. Leeper, Jr. 1996. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109:1019-1029.
    • (1996) Chest , vol.109 , pp. 1019-1029
    • Crouch Brewer, S.1    Wunderink, R.G.2    Jones, C.B.3    Leeper Jr., K.V.4
  • 4
    • 0020658136 scopus 로고
    • Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide
    • Cryz, S. J., Jr., E. Furer, and R. Germanier. 1983. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide. Infect. Immun. 39:1072-1079.
    • (1983) Infect. Immun. , vol.39 , pp. 1072-1079
    • Cryz Jr., S.J.1    Furer, E.2    Germanier, R.3
  • 6
    • 0023267602 scopus 로고
    • Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin a conjugates
    • Cryz, S. J., Jr., A. B. Lang, J. C. Sadoff, R. Germanier, and E. Furer. 1987. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates. Infect. Immun. 55:1547-1551.
    • (1987) Infect. Immun. , vol.55 , pp. 1547-1551
    • Cryz Jr., S.J.1    Lang, A.B.2    Sadoff, J.C.3    Germanier, R.4    Furer, E.5
  • 7
    • 0018777674 scopus 로고
    • In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains
    • Desgranges, C., M. F. Lavoue, J. Patet, and G. de-The. 1979. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains. Biomedicine 30:102-108.
    • (1979) Biomedicine , vol.30 , pp. 102-108
    • Desgranges, C.1    Lavoue, M.F.2    Patet, J.3    De-The, G.4
  • 8
    • 39149111898 scopus 로고    scopus 로고
    • Vaccines and immunotherapy against Pseudomonas aeruginosa
    • Doring, G., and G. B. Pier. 2008. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 26:1011-1024.
    • (2008) Vaccine , vol.26 , pp. 1011-1024
    • Doring, G.1    Pier, G.B.2
  • 10
    • 0035680987 scopus 로고    scopus 로고
    • Infection control in the ICU
    • Eggimann, P., and D. Pittet. 2001. Infection control in the ICU. Chest 120:2059-2093.
    • (2001) Chest , vol.120 , pp. 2059-2093
    • Eggimann, P.1    Pittet, D.2
  • 11
    • 0015263647 scopus 로고
    • Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease
    • Falk, G. A., A. J. Okinaka, and G. W. Siskind. 1972. Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 105:14-21.
    • (1972) Am. Rev. Respir. Dis. , vol.105 , pp. 14-21
    • Falk, G.A.1    Okinaka, A.J.2    Siskind, G.W.3
  • 12
    • 0030692764 scopus 로고    scopus 로고
    • Pharmacokinetics, tolerability, and preliminary efficacy of human anti-Pseudomonas aeruginosa monoclonal antibodies in pneumonia and burn infection patients
    • Harrison, F. J., D. Rohm, T. Kohzuki, and H. Noguchi. 1997. Pharmacokinetics, tolerability, and preliminary efficacy of human anti-Pseudomonas aeruginosa monoclonal antibodies in pneumonia and burn infection patients. Hybridoma 16:413-420.
    • (1997) Hybridoma , vol.16 , pp. 413-420
    • Harrison, F.J.1    Rohm, D.2    Kohzuki, T.3    Noguchi, H.4
  • 13
    • 0032434029 scopus 로고    scopus 로고
    • Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies
    • Jansen, W. T., J. Gootjes, M. Zelle, D. V. Madore, J. Verhoef, H. Snippe, and A. F. Verheul. 1998. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin. Diagn. Lab. Immunol. 5:703-710.
    • (1998) Clin. Diagn. Lab. Immunol. , vol.5 , pp. 703-710
    • Jansen, W.T.1    Gootjes, J.2    Zelle, M.3    Madore, D.V.4    Verhoef, J.5    Snippe, H.6    Verheul, A.F.7
  • 15
    • 0025078706 scopus 로고
    • Polysaccharide antigens of Pseudomonas aeruginosa
    • Knirel, Y. A. 1990. Polysaccharide antigens of Pseudomonas aeruginosa. Crit. Rev. Microbiol. 17:273-304.
    • (1990) Crit. Rev. Microbiol. , vol.17 , pp. 273-304
    • Knirel, Y.A.1
  • 16
    • 0028788729 scopus 로고
    • The effect of late-onset ventilator-associated pneumonia in determining patient mortality
    • Kollef, M. H., P. Silver, D. M. Murphy, and E. Trovillion. 1995. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:1655-1662.
    • (1995) Chest , vol.108 , pp. 1655-1662
    • Kollef, M.H.1    Silver, P.2    Murphy, D.M.3    Trovillion, E.4
  • 17
    • 0021721095 scopus 로고
    • A human hybrid myeloma for production of human monoclonal antibodies
    • Kozbor, D., P. Tripputi, J. C. Roder, and C. M. Croce. 1984. A human hybrid myeloma for production of human monoclonal antibodies. J. Immunol. 133: 3001-3005. (Pubitemid 15216494)
    • (1984) Journal of Immunology , vol.133 , Issue.6 , pp. 3001-3005
    • Kozbor, D.1    Tripputi, P.2    Roder, J.C.3    Croce, C.M.4
  • 18
    • 0028051537 scopus 로고
    • Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat
    • Landsperger, W. J., K. D. Kelly-Wintenberg, T. C. Montie, L. S. Knight, M. B. Hansen, C. C. Huntenburg, and M. J. Schneidkraut. 1994. Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. Infect. Immun. 62:4825-4830.
    • (1994) Infect. Immun. , vol.62 , pp. 4825-4830
    • Landsperger, W.J.1    Kelly-Wintenberg, K.D.2    Montie, T.C.3    Knight, L.S.4    Hansen, M.B.5    Huntenburg, C.C.6    Schneidkraut, M.J.7
  • 19
    • 0025646578 scopus 로고
    • Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization
    • Lang, A. B., E. Furer, G. Senyk, J. W. Larrick, and S. J. Cryz, Jr. 1990. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Hum. Antibodies Hybridomas 1:96-103.
    • (1990) Hum. Antibodies Hybridomas , vol.1 , pp. 96-103
    • Lang, A.B.1    Furer, E.2    Senyk, G.3    Larrick, J.W.4    Cryz Jr., S.J.5
  • 20
    • 3042638668 scopus 로고    scopus 로고
    • Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection
    • Lang, A. B., A. Rudeberg, M. H. Schoni, J. U. Que, E. Furer, and U. B. Schaad. 2004. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr. Infect. Dis. J. 23:504-510.
    • (2004) Pediatr. Infect. Dis. J. , vol.23 , pp. 504-510
    • Lang, A.B.1    Rudeberg, A.2    Schoni, M.H.3    Que, J.U.4    Furer, E.5    Schaad, U.B.6
  • 21
    • 0028862352 scopus 로고
    • Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
    • Lang, A. B., U. B. Schaad, A. Rudeberg, J. Wedgwood, J. U. Que, E. Furer, and S. J. Cryz, Jr. 1995. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J. Pediatr. 127:711-717.
    • (1995) J. Pediatr. , vol.127 , pp. 711-717
    • Lang, A.B.1    Schaad, U.B.2    Rudeberg, A.3    Wedgwood, J.4    Que, J.U.5    Furer, E.6    Cryz Jr., S.J.7
  • 22
    • 0026783618 scopus 로고
    • Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium
    • Lang, A. B., U. Schurch, F. Zimmermann, and U. Bruderer. 1992. Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium. J. Immunol. Methods 154:21-26.
    • (1992) J. Immunol. Methods , vol.154 , pp. 21-26
    • Lang, A.B.1    Schurch, U.2    Zimmermann, F.3    Bruderer, U.4
  • 23
    • 67749124368 scopus 로고    scopus 로고
    • Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers
    • Lazar, H., M. P. Horn, A. W. Zuercher, M. A. Imboden, P. Durrer, M. Seiberling, R. Pokorny, C. Hammer, and A. B. Lang. 2009. Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers. Antimicrob. Agents Chemother. 53:3442-3446.
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 3442-3446
    • Lazar, H.1    Horn, M.P.2    Zuercher, A.W.3    Imboden, M.A.4    Durrer, P.5    Seiberling, M.6    Pokorny, R.7    Hammer, C.8    Lang, A.B.9
  • 24
    • 0032798037 scopus 로고    scopus 로고
    • A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine
    • Martinez, J. E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G. M. Carlone. 1999. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
    • (1999) Clin. Diagn. Lab. Immunol. , vol.6 , pp. 581-586
    • Martinez, J.E.1    Romero-Steiner, S.2    Pilishvili, T.3    Barnard, S.4    Schinsky, J.5    Goldblatt, D.6    Carlone, G.M.7
  • 26
    • 0028557981 scopus 로고
    • Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial
    • McCloskey, R. V., R. C. Straube, C. Sanders, S. M. Smith, C. R. Smith, et al. 1994. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 121:1-5.
    • (1994) Ann. Intern. Med. , vol.121 , pp. 1-5
    • McCloskey, R.V.1    Straube, R.C.2    Sanders, C.3    Smith, S.M.4    Smith, C.R.5
  • 27
    • 0027393911 scopus 로고
    • Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients
    • Meng, Y. G., T. Wong, L. D. Saravolatz, and J. E. Pennington. 1993. Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients. J. Infect. Dis. 167:784-785.
    • (1993) J. Infect. Dis. , vol.167 , pp. 784-785
    • Meng, Y.G.1    Wong, T.2    Saravolatz, L.D.3    Pennington, J.E.4
  • 28
    • 11244299890 scopus 로고    scopus 로고
    • Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital
    • Muller-Premru, M., and M. Gubina. 2000. Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralbl. Bakteriol. 289:857-867.
    • (2000) Zentralbl. Bakteriol. , vol.289 , pp. 857-867
    • Muller-Premru, M.1    Gubina, M.2
  • 29
    • 40649127250 scopus 로고    scopus 로고
    • Anti-infective antibodies: A novel tool to prevent and treat nosocomial diseases
    • Nagy, E., C. Giefing, and A. von Gabain. 2008. Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases. Expert Rev. Anti-Infect. Ther. 6:21-30.
    • (2008) Expert Rev. Anti-Infect. Ther. , vol.6 , pp. 21-30
    • Nagy, E.1    Giefing, C.2    Von Gabain, A.3
  • 30
    • 0025968886 scopus 로고
    • Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa
    • Ochi, H., H. Ohtsuka, S. Yokota, I. Uezumi, M. Terashima, K. Irie, and H. Noguchi. 1991. Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa. Infect. Immun. 59:550-554.
    • (1991) Infect. Immun. , vol.59 , pp. 550-554
    • Ochi, H.1    Ohtsuka, H.2    Yokota, S.3    Uezumi, I.4    Terashima, M.5    Irie, K.6    Noguchi, H.7
  • 31
    • 34547531757 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation, and target for effective immunity
    • Pier, G. B. 2007. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation, and target for effective immunity. Int. J. Med. Microbiol. 297:277-295.
    • (2007) Int. J. Med. Microbiol. , vol.297 , pp. 277-295
    • Pier, G.B.1
  • 33
    • 33644782751 scopus 로고    scopus 로고
    • Anti-infective monoclonal antibodies: Perils and promise of development
    • Reichert, J. M., and M. C. Dewitz. 2006. Anti-infective monoclonal antibodies: perils and promise of development. Nat. Rev. Drug Discov. 5:191-195.
    • (2006) Nat. Rev. Drug Discov. , vol.5 , pp. 191-195
    • Reichert, J.M.1    Dewitz, M.C.2
  • 34
    • 0016120684 scopus 로고
    • Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage
    • Reynolds, H. Y., and H. H. Newball. 1974. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J. Lab. Clin. Med. 84:559-573.
    • (1974) J. Lab. Clin. Med. , vol.84 , pp. 559-573
    • Reynolds, H.Y.1    Newball, H.H.2
  • 35
    • 0015694635 scopus 로고
    • Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa
    • Reynolds, H. Y., and R. E. Thompson. 1973. Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa. J. Immunol. 111:358-368.
    • (1973) J. Immunol. , vol.111 , pp. 358-368
    • Reynolds, H.Y.1    Thompson, R.E.2
  • 36
    • 0032831499 scopus 로고    scopus 로고
    • Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa
    • Rocchetta, H. L., L. L. Burrows, and J. S. Lam. 1999. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 63:523-553.
    • (1999) Microbiol. Mol. Biol. Rev. , vol.63 , pp. 523-553
    • Rocchetta, H.L.1    Burrows, L.L.2    Lam, J.S.3
  • 38
    • 0026095292 scopus 로고
    • Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients
    • Saravolatz, L. D., N. Markowitz, M. S. Collins, D. Bogdanoff, and J. E. Pennington. 1991. Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients. J. Infect. Dis. 164:803-806.
    • (1991) J. Infect. Dis. , vol.164 , pp. 803-806
    • Saravolatz, L.D.1    Markowitz, N.2    Collins, M.S.3    Bogdanoff, D.4    Pennington, J.E.5
  • 39
    • 0023549786 scopus 로고
    • Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa
    • Sawada, S., T. Kawamura, and Y. Masuho. 1987. Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa. J. Gen. Microbiol. 133:3581-3590.
    • (1987) J. Gen. Microbiol. , vol.133 , pp. 3581-3590
    • Sawada, S.1    Kawamura, T.2    Masuho, Y.3
  • 40
    • 0025950064 scopus 로고
    • Safety and immunogenicity of Pseudomonas aeruginosa conjugate a vaccine in cystic fibrosis
    • Schaad, U. B., A. B. Lang, J. Wedgwood, A. Ruedeberg, J. U. Que, E. Furer, and S. J. Cryz, Jr. 1991. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet 338:1236-1237.
    • (1991) Lancet , vol.338 , pp. 1236-1237
    • Schaad, U.B.1    Lang, A.B.2    Wedgwood, J.3    Ruedeberg, A.4    Que, J.U.5    Furer, E.6    Cryz Jr., S.J.7
  • 41
    • 0029941969 scopus 로고    scopus 로고
    • Generation and characterization of a human monoclonal IgM antibody that recognizes a conserved epitope shared by lipopolysaccharides of different gram-negative bacteria
    • Seifert, M., G. Schoenherr, D. Roggenbuck, U. Marx, and R. von Baehr. 1996. Generation and characterization of a human monoclonal IgM antibody that recognizes a conserved epitope shared by lipopolysaccharides of different gram-negative bacteria. Hybridoma 15:191-198. (Pubitemid 26240435)
    • (1996) Hybridoma , vol.15 , Issue.3 , pp. 191-198
    • Seifert, M.1    Schoenherr, G.2    Roggenbuck, D.3    Marx, U.4    Von Baehr, R.5
  • 43
    • 0031772804 scopus 로고    scopus 로고
    • Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia
    • Song, Z., A. Kharazmi, H. Wu, V. Faber, C. Moser, H. K. Krogh, J. Rygaard, and N. Hoiby. 1998. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin. Diagn. Lab. Immunol. 5:882-887.
    • (1998) Clin. Diagn. Lab. Immunol. , vol.5 , pp. 882-887
    • Song, Z.1    Kharazmi, A.2    Wu, H.3    Faber, V.4    Moser, C.5    Krogh, H.K.6    Rygaard, J.7    Hoiby, N.8
  • 44
    • 0024805809 scopus 로고
    • Biological role of different antibody classes
    • Spiegelberg, H. L. 1989. Biological role of different antibody classes. Int. Arch. Allergy Appl. Immunol. 90(Suppl. 1):22-27.
    • (1989) Int. Arch. Allergy Appl. Immunol. , vol.90 , Issue.SUPPL. 1 , pp. 22-27
    • Spiegelberg, H.L.1
  • 45
    • 36549038193 scopus 로고    scopus 로고
    • Monoclonal antibodies for prophylaxis and therapy of infectious diseases
    • ter Meulen, J. 2007. Monoclonal antibodies for prophylaxis and therapy of infectious diseases. Expert Opin. Emerg. Drugs 12:525-540.
    • (2007) Expert Opin. Emerg. Drugs , vol.12 , pp. 525-540
    • Ter Meulen, J.1
  • 46
    • 33745112513 scopus 로고    scopus 로고
    • Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis
    • Zuercher, A. W., M. P. Horn, J. U. Que, A. Ruedeberg, M. H. Schoeni, U. B. Schaad, P. Marcus, and A. B. Lang. 2006. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol. Med. Microbiol. 47: 302-308.
    • (2006) FEMS Immunol. Med. Microbiol. , vol.47 , pp. 302-308
    • Zuercher, A.W.1    Horn, M.P.2    Que, J.U.3    Ruedeberg, A.4    Schoeni, M.H.5    Schaad, U.B.6    Marcus, P.7    Lang, A.B.8
  • 48
    • 0023876799 scopus 로고
    • X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa
    • Zweerink, H. J., M. C. Gammon, C. F. Hutchison, J. J. Jackson, G. B. Pier, J. M. Puckett, T. J. Sewell, and N. H. Sigal. 1988. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa. Infect. Immun. 56:1209-1214.
    • (1988) Infect. Immun. , vol.56 , pp. 1209-1214
    • Zweerink, H.J.1    Gammon, M.C.2    Hutchison, C.F.3    Jackson, J.J.4    Pier, G.B.5    Puckett, J.M.6    Sewell, T.J.7    Sigal, N.H.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.